Athersys (ATHX) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock ATHX vs. UPC, HEPA, HSTO, SCPS, VAXX, EVLO, CMRA, ARDS, STAB, and CALAShould you be buying Athersys stock or one of its competitors? The main competitors of Athersys include Universe Pharmaceuticals (UPC), Hepion Pharmaceuticals (HEPA), Histogen (HSTO), Scopus BioPharma (SCPS), Vaxxinity (VAXX), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical preparations" industry. Athersys vs. Universe Pharmaceuticals Hepion Pharmaceuticals Histogen Scopus BioPharma Vaxxinity Evelo Biosciences Comera Life Sciences Aridis Pharmaceuticals Statera Biopharma Calithera Biosciences Athersys (NASDAQ:ATHX) and Universe Pharmaceuticals (NYSE:UPC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, profitability and earnings. Is ATHX or UPC more profitable? Company Net Margins Return on Equity Return on Assets AthersysN/A N/A -223.03% Universe Pharmaceuticals N/A N/A N/A Does the media favor ATHX or UPC? In the previous week, Athersys had 1 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 1 mentions for Athersys and 0 mentions for Universe Pharmaceuticals. Universe Pharmaceuticals' average media sentiment score of 0.80 beat Athersys' score of 0.00 indicating that Universe Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Athersys Neutral Universe Pharmaceuticals Positive Do insiders and institutionals believe in ATHX or UPC? 19.4% of Athersys shares are held by institutional investors. Comparatively, 0.2% of Universe Pharmaceuticals shares are held by institutional investors. 0.0% of Athersys shares are held by insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk and volatility, ATHX or UPC? Athersys has a beta of -0.9, suggesting that its stock price is 190% less volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.55, suggesting that its stock price is 55% more volatile than the S&P 500. Which has stronger valuation & earnings, ATHX or UPC? Universe Pharmaceuticals has higher revenue and earnings than Athersys. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAthersys$146K0.00-$72.53M-$2.03N/AUniverse Pharmaceuticals$26.73M0.01-$6.16MN/AN/A Does the MarketBeat Community favor ATHX or UPC? Athersys received 365 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformAthersysOutperform Votes36556.77% Underperform Votes27843.23% Universe PharmaceuticalsN/AN/A SummaryUniverse Pharmaceuticals beats Athersys on 6 of the 9 factors compared between the two stocks. Remove Ads Get Athersys News Delivered to You Automatically Sign up to receive the latest news and ratings for ATHX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATHX vs. The Competition Export to ExcelMetricAthersysPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$833,000.00$6.91B$5.64B$8.06BDividend YieldN/A2.73%4.56%4.02%P/E Ratio0.007.2023.1319.03Price / SalesN/A226.00383.8993.17Price / CashN/A65.6738.1634.64Price / BookN/A6.476.944.33Net Income-$72.53M$141.90M$3.20B$247.06M Athersys Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATHXAthersysN/AN/AN/AN/A$833,000.00$146,000.000.0024UPCUniverse PharmaceuticalsN/A$0.10-4.8%N/A-99.6%$168,000.00$26.73M0.00220Gap DownHEPAHepion Pharmaceuticals0.6875 of 5 stars$0.02-9.6%N/A-99.4%$145,000.00N/A0.0020Short Interest ↓Gap DownHigh Trading VolumeHSTOHistogenN/A$0.03flatN/A-92.2%$128,000.00$19,000.00-0.0120SCPSScopus BioPharmaN/A$0.00flatN/A-87.5%$13,000.00N/A0.009News CoverageVAXXVaxxinityN/A$0.00-99.8%N/A-92.3%$13,000.00N/A0.0090Gap DownEVLOEvelo BiosciencesN/A$0.00flatN/A-99.0%$9,000.00N/A0.00120CMRAComera Life SciencesN/A$0.00flatN/A-99.4%$6,000.00$1.00M0.002ARDSAridis PharmaceuticalsN/A$0.00flatN/AN/A$5,000.00$3.09M0.0030STABStatera BiopharmaN/A$0.00flatN/A-83.3%$5,000.00N/A0.0020CALACalithera BiosciencesN/A$0.00flatN/A-97.0%$3,000.00N/A0.0060Analyst Forecast Remove Ads Related Companies and Tools Related Companies Universe Pharmaceuticals Competitors Hepion Pharmaceuticals Competitors Histogen Competitors Scopus BioPharma Competitors Vaxxinity Competitors Evelo Biosciences Competitors Comera Life Sciences Competitors Aridis Pharmaceuticals Competitors Statera Biopharma Competitors Calithera Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATHX) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Athersys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Athersys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATHX Stock Free ATHX Stock Alerts